We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us

Download Mobile App




Early Detection of Pseudomonas aeruginosa Increases Survival Chances

By Labmedica staff writers
Posted on 29 Jul 2008
A technique has been developed for the early detection of superbug Pseudomonas aeruginosa, which particularly infects patients with cystic fibrosis.

In the new diagnostic method, a non-colored compound reacts with an enzyme present in the bacteria and produces a very distinctive purple color. More...
The technique works on 99% of the strains P. aeruginosa.

The bacteria infect the fluid in the lungs of cystic fibrosis patients and also attack patients with localized and systemic immune defects, such as those suffering from burns, patients with AIDS, and cancer. P. aeruginosa accounts for 10% of all nosocomial infections, according to the Centers for Disease Control and Prevention in the United States (CDC; Atlanta, GA, USA).

The infections are difficult to treat because the bacteria are tolerant to many detergents, disinfectants, and antimicrobial compounds. They are especially difficult to control in hospitals and institutional environments and therefore hospital staff needs to diagnose the cause of the infections very quickly.

Researchers from the University of Sunderland (UK), the North Umbria University (Newcastle, UK), and bioMérieux, France
(Marcy l'Etoile) developed the technique that can identify Pseudomonas within 24-48 hours of infection, greatly increasing the patient's chances of survival.


Related Links:
Centers for Disease Control and Prevention in the United States
University of Sunderland
bioMérieux

Gold Member
Quantitative POC Immunoassay Analyzer
EASY READER+
Online QC Software
Acusera 24•7
New
Japanese Encephalitis Test
Japanese Encephalitis Virus Real Time PCR Kit
New
Automated Clinical Chemistry Analyzer
Envoy 500+
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Molecular Diagnostics

view channel
Image: Researchers identified blood-based genomic signatures characteristic of inflammatory breast cancer (photo courtesy of Shutterstock)

Liquid Biopsy Biomarkers Distinguish Inflammatory Breast Cancer and Support Monitoring

Inflammatory breast cancer is among the most aggressive forms of breast malignancy and remains challenging to diagnose and monitor. Obtaining tumor tissue can be difficult, and standard genome and RNA... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.